Treatment of borderline elevated thyrotropin levels--reply

Affiliations

Comment

Peter N Taylor et al. JAMA Intern Med. 2015 Mar.

. 2015 Mar;175(3):466-7.

doi: 10.1001/jamainternmed.2014.7862.

¹ Thyroid Research Group, Institute of Molecular Medicine, Cardiff University School of Medicine, Cardiff, Wales.

No abstract available

Comment on

Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study.
Taylor PN, Iqbal A, Minassian C, Sayers A, Draman MS, Greenwood R, Hamilton W, Okosieme O, Panicker V, Thomas SL, Dayan C. Taylor PN, et al. JAMA Intern Med. 2014 Jan;174(1):32-9. doi: 10.1001/jamainternmed.2013.11312. JAMA Intern Med. 2014. PMID: 24100714
Treatment of borderline elevated thyrotropin levels.
Braithwaite SS, Moore JB. Braithwaite SS, et al. JAMA Intern Med. 2015 Mar;175(3):465-6. doi: 10.1001/jamainternmed.2014.7841. JAMA Intern Med. 2015. PMID: 25730571 No abstract available.
Treatment of borderline elevated thyrotropin levels.
Jolobe OM. Jolobe OM. JAMA Intern Med. 2015 Mar;175(3):466. doi: 10.1001/jamainternmed.2014.7847. JAMA Intern Med. 2015. PMID: 25730573 No abstract available.